Show results for
Refine by
Applications
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Multi-Cancer Platform for Clinical Trials
Pancreas Cancer Equipment & Supplies
157 equipment items found
Manufactured by:ClearChem Diagnostics, Inc. based inOntario, CALIFORNIA (USA)
Amylase reagent is used to help determine whether a patient may have disorders involving the pancreas and is often used in the monitoring of pancreatic cancer. Our kit, bottled and barcoded for the Olympus Au400 and other AU series Chemistry analyzers, contains four 60ml bottles and has had its set up parameters modified validated and verified by our clinical ...
Manufactured by:Shengkang Fine Chemical Co., Ltd based inHong Kong, CHINA
Name Erlotinib. Molecular Formula C22H23N3O4. Molecular Weight 393.44. CAS Registry Number 183321-74-6. Application Treatment of pancreatic cancer. ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
KRAS G12C inhibitor 61 inhibits phosphorylated ERK 1/2 in MIA PaCa-2 cells with an IC50 of 9 nM. KRAS G12C inhibitor 61 may be used in studies of pancreatic, colorectal, and lung cancers. ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
CM03 is a potent ligand for DNA G-quadruplexes (G4s). CM03 stabilizes G4, downregulates more G4-containing genes, and increases the incidence of double-strand break events (DSBs) due to torsional strains on DNA and chromatin structures. CM03 has selective potency against pancreatic cancer cells. ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
ICy-OH is an iodinated photosensitizer and an effective anticancer agent. ICy-OH can not only be used for deep tissue imaging (λex=640 nm, λem=690-740 nm), but also selectively induce pancreatic cancer cell death through the pyroptosis pathway. ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES028 is a potential first-in-class SIRPα/CLDN18.2 bsAb developed using our Bispecific Macrophage Engager (BiME®) platform. The SIRPα antibody blocks the “don’t-eat-me” signal while the TAA antibody provides an “eat-me” signal through Fc receptor engagement. ES028 and the BiME platform are designed for potent activation of phagocytosis and directly ...
Manufactured by:BridgeBio Pharma, Inc. based inPalo Alto, CALIFORNIA (USA)
RAS is one of the most well-known oncogenic drivers, with approximately 30% of all cancers being driven by RAS mutations, including large proportions of lung, colorectal and pancreatic tumors. BridgeBio’s approach to RAS cancers encompasses multiple “shots on goal” that target both KRAS mutant tumors and those in which RAS activates PI3Ka. We believe two of our approaches have ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
Bis-Pro-5FU is a 5-FU precursor that confers oral bioavailability and improves the safety of 5-fluorouracil (5-FU) chemotherapy regimens. 5-FU is an antitumor antimetabolite that is widely used in colorectal and pancreatic cancer research. ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Aplidine is a compound found in tunicates which shows promise in shrinking tumors in pancreatic, stomach, bladder, and prostate cancers. The specific marine organism is Aplidium albicans. Aplidine consists of peptide molecules. In addition to the cancers mentioned above it is also under consideration as a treatment for some types of ...
by:Debiopharm based inLausanne, SWITZERLAND
Oxaliplatin is a diaminocyclohexane (DACH) platin. It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction of oxaliplatin, the standard of care for colorectal cancer was 5-fluorouracil (5-FU). Combination of oxaliplatin with 5-FU and leucovorin (FOLFOX) ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
KP372-1 is an Akt inhibitor that inhibits proliferation and induces apoptosis and anoikis. KP372-1 is also an NQO1 redox cycling agent that causes DNA damage (including DNA breakage) by generating ROS. KP372-1 can be used in cancer research (such as head and neck squamous cell carcinoma (HNSCC) and pancreatic cancer). ...
by:VisionGate, Inc based inPhoenix, ARIZONA (USA)
Smart, Accurate, & Dynamic. Our AI Learns about Your Cells Fast. In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are completely normal in your ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
P12FR2 aptamer sodium is a 2'-fluoropyrimidine-modified RNA aptamer targeting human PAUF with an estimated apparent KD of 77 nM. The P12FR2 aptamer sodium inhibits PAUF-induced migration of PANC-1 (human pancreatic cancer cells) in a wound healing assay and suppresses tumor growth in a mouse CFPAC-1 pancreatic cancer ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug used to treat colorectal cancer with peak global ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
AV-203 (CAN017) is a clinical-stage ErbB3 (HER3) inhibitory antibody candidate designed to inhibit both ligand-dependent and ligand-independent ErbB3 signaling. ErbB3 is a receptor that is typically expressed in many human cancers, and AV-203 has demonstrated preclinical activity in a number of different tumor models including breast, head and neck, lung, ovarian and pancreatic ...
Manufactured by:Universal Diagnostics SL based inSeville, SPAIN
We are developing Signal-X, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
Elucigene DPYD assay is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered. 5-fluorouracil (5-FU) is a chemotherapy agent used to treat a range of cancers including colorectal, head and neck, breast, pancreatic and stomach cancer. 5-FU is metabolized by the dihydropyrimidine dehydrogenase enzyme (DPD) which is encoded by the ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
Axl-IN-7 (Chemie 22) is a potent AXL inhibitor. Axl-IN-7 can be used to study Axl-related diseases, such as cancer (such as acute myeloid leukemia, melanoma, breast cancer, pancreatic cancer and glioma), kidney disease, immune system disease and cardiovascular disease. ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:BRCA1, BRCA2 whole exome sequencing and Includes ±20 bp regions at exon-intron junctions. Detection Significance:Predicting prognosis ;Auxiliary diagnosis;Guiding the selection of ...